Projects per year
Personal profile
Expertise
- Bone marrow and peripheral blood stem cells: biology and therapeutical use
- Stem cell processing and banking
- Tumo-host interactions in blood cancer (multiple myeloma)
Fingerprint
Dive into the research topics where Ivan Van Riet is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 12 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
FWOSB118: Tumor characterization and disease follow-up in multiple myeloma by (epi) genetic profiling using liquid biopsies
Heestermans, R. & Van Riet, I.
1/11/21 → 31/10/25
Project: Fundamental
-
-
ANI52: Cycle for Life 2007 : Circulating endothelial cells in multiple myeloma: characterisation and study of their role as surrogate marker for myeloma-induced angiogenesis.
Vande Broek, I. & Van Riet, I.
27/09/07 → …
Project: Fundamental
Research output
-
A randomized phase II clinical trial of stereotactic body radiation therapy (SBRT) and systemic pembrolizumab with or without intratumoral avelumab/ipilimumab plus CD1c (BDCA-1)+/CD141 (BDCA-3)+ myeloid dendritic cells in solid tumors
Vounckx, M., Tijtgat, J., Stevens, L., Dirven, I., Ilsen, B., Vandenbroucke, F., Raeymaeckers, S., Vekens, K., Forsyth, R., Geeraerts, X., Van Riet, I., Schwarze, J. K., Tuyaerts, S., Decoster, L., De Ridder, M., Dufait, I. & Neyns, B., 2 Jul 2024, In: Cancer Immunol Immunother. 73, 9, 8 p., 167.Research output: Contribution to journal › Article › peer-review
Open AccessFile1 Downloads (Pure) -
Comprehensive (Epi)Genetic Tumor Characterization and Disease Follow-Up in Multiple Myeloma Using Blood-Derived Cell-Free DNA
Heestermans, R., Olsen, C., Succari, J., Ameli, S., Janssen, T., De Becker, A., Vande Broek, I., Bakkus, M. H. C., Schots, R., De Bruyne, E. & Van Riet, I., 5 Nov 2024.Research output: Unpublished contribution to conference › Poster
-
Een innovatieve, niet-invasieve strategie voor mutatieanalyse bij multipel myeloom: liquid biopsies op de weg naar gepersonaliseerde geneeskunde
Heestermans, R., Schots, R., De Becker, A. & Van Riet, I., 14 Oct 2024, In: OncoHemato. 18, 5, p. 22-24 3 p.Research output: Contribution to journal › Article › peer-review
-
Feasibility of co-transplantation of umbilical cord blood and third-party mesenchymal stromal cells after (non)myeloablative conditioning in patients with hematological malignancies
Transplant Committee of the Belgian Hematology Society., Planken, S., De Becker, A., Kerre, T., Schoemans, H., Baron, F., Graux, C., Van Riet, I., Lechanteur, C., Baudoux, E., Schots, R. & Beguin, Y., Dec 2024, In: Current research in translational medicine. 72, 4, 5 p., 103466.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
Intratumoral administration of the immunologic adjuvant AS01B in combination with autologous CD1c (BDCA-1)+/CD141 (BDCA-3)+ myeloid dendritic cells plus ipilimumab and intravenous nivolumab in patients with refractory advanced melanoma
Tijtgat, J., Geeraerts, X., Boisson, A., Stevens, L., Vounckx, M., Dirven, I., Schwarze, J. K., Raeymaeckers, S., Forsyth, R., Van Riet, I., Tuyaerts, S., Willard-Gallo, K. & Neyns, B., 11 Jan 2024, In: Journal for ImmunoTherapy of Cancer. 12, 1, 12 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile3 Citations (Scopus)2 Downloads (Pure)
Activities
-
Characterization of the evolving mutational landscape in multiple myeloma during disease progression using blood-derived cell free DNA: an explorative study
Robbe Heestermans (Speaker), Wouter De Brouwer (Contributor), Ken Maes (Contributor), Isabelle Vande Broek (Contributor), Freya Vaeyens (Contributor), Catharina Olsen (Contributor), Toon Janssen (Contributor), Ann De Becker (Contributor), Marleen Bakkus (Contributor), Henri Schots (Contributor) & Ivan Van Riet (Contributor)
3 Feb 2023Activity: Talk or presentation › Talk or presentation at a conference
-
The best liquid biopsy for myeloma detection by immunoglobulin targeted NGS
Wouter De Brouwer (Speaker), Ivan Van Riet (Contributor), Robbe Heestermans (Contributor), Jona Van der Straeten (Contributor), Isabelle Vande Broek (Contributor), Marleen Bakkus (Contributor) & Henri Schots (Contributor)
4 Feb 2022Activity: Talk or presentation › Talk or presentation at a conference
-
Lab Secrets for Stratification and Prognoses of Leukemia and Multiple Myeloma using Next-Generation Sequencing (NGS): Strategies to Leverage NGS-based minimal residual disease (MRD) in Multiple Myeloma (MM) and Acute Lymphoblastic Leukemia (ALL)
Wouter De Brouwer (Invited speaker), Jona Van der Straeten (Contributor), Ivan Van Riet (Contributor) & Marleen Bakkus (Contributor)
24 Feb 2022Activity: Talk or presentation › Talk at a public lecture/debate
-
29th General Annual Meeting of the Belgian Hematological Society
Ivan Van Riet (Speaker)
30 Jan 2014 → 31 Jan 2014Activity: Talk or presentation › Talk or presentation at a workshop/seminar
-
15th Post-ASH meeting
Ivan Van Riet (Participant)
11 Jan 2013Activity: Participating in or organising an event › Participation in workshop, seminar